Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 914 citations · Seema Khan
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 841 citations · Seema Khan
American Society for Metabolic and Bariatric Surgery 2022 estimate of metabolic and bariatric procedures performed in the United States.
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2024 · 199 citations · Richard Peterson
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 289 citations · Seema Khan
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026.
Journal of the National Comprehensive Cancer Network : JNCCN · 2026 · 33 citations · Seema Khan
Current and emerging strategies for the prevention of hepatocellular carcinoma.
Nature reviews. Gastroenterology & hepatology · 2025 · 64 citations ·
Aquablation Therapy in Large Prostates (80-150 mL) for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Final WATER II 5-Year Clinical Trial Results.
The Journal of urology · 2023 · 45 citations · Gopal Badlani
Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 161 citations · Seema Khan